RetinalGenix Technologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2018
Selling, General & Admin	1.3	1.33	0.9	0.81	1.12	Upgrade
Research & Development	0.08	0.37	0.52	0.81	0.75	Upgrade
Operating Expenses	2.42	4.32	2.09	1.88	2.18	Upgrade
Operating Income	-2.42	-4.32	-2.09	-1.88	-2.18	Upgrade
Interest Expense	-0	-0	-0	-0.01	-0	Upgrade
EBT Excluding Unusual Items	-2.43	-4.32	-2.09	-1.88	-2.18	Upgrade
Pretax Income	-2.43	-4.32	-2.09	-3.91	-2.18	Upgrade
Net Income	-2.43	-4.32	-2.09	-3.91	-2.18	Upgrade
Net Income to Common	-2.43	-4.32	-2.09	-3.91	-2.18	Upgrade
Shares Outstanding (Basic)	19	18	17	16	41	Upgrade
Shares Outstanding (Diluted)	19	18	17	16	41	Upgrade
Shares Change (YoY)	3.47%	3.39%	11.34%	-62.22%	3.91%	Upgrade
EPS (Basic)	-0.13	-0.24	-0.12	-0.25	-0.05	Upgrade
EPS (Diluted)	-0.13	-0.24	-0.12	-0.25	-0.05	Upgrade
Free Cash Flow	-0.56	-0.74	-0.45	-0.2	-1.17	Upgrade
Free Cash Flow Per Share	-0.03	-0.04	-0.03	-0.01	-0.03	Upgrade
EBITDA	-2.42	-4.32	-2.09	-1.88	-	Upgrade
D&A For EBITDA	0	0	0	0	-	Upgrade
EBIT	-2.42	-4.32	-2.09	-1.88	-2.18	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.